Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Comparative immunohistochemical analysis of ochratoxin A tumourigenesis in rats and urinary tract carcinoma in humans; mechanistic significance of p-S6 ribosomal protein expression.

Gazinska P, Herman D, Gillett C, Pinder S, Mantle P.

Toxins (Basel). 2012 Sep;4(9):643-62. doi: 10.3390/toxins4090643. Epub 2012 Sep 11.

2.

A pilot study of nuclear instability in archived renal and upper urinary tract tumours with putative ochratoxin aetiology.

Mantle PG, Amerasinghe C, Brown AL, Herman D, Horn T, Krogh T, Odell EW, Rosenbaum T, Tatu CA.

Toxins (Basel). 2010 Mar;2(3):326-40. doi: 10.3390/toxins2030326. Epub 2010 Mar 9.

3.
4.

Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A.

Mantle P, Kulinskaya E, Nestler S.

Food Addit Contam. 2005;22 Suppl 1:58-64.

PMID:
16332623
5.

Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction.

Castegnaro M, Mohr U, Pfohl-Leszkowicz A, Estève J, Steinmann J, Tillmann T, Michelon J, Bartsch H.

Int J Cancer. 1998 Jul 3;77(1):70-5.

6.

Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line.

Horvath A, Upham BL, Ganev V, Trosko JE.

Toxicon. 2002 Mar;40(3):273-82.

PMID:
11711124
7.

Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model.

Sahin K, Cross B, Sahin N, Ciccone K, Suleiman S, Osunkoya AO, Master V, Harris W, Carthon B, Mohammad R, Bilir B, Wertz K, Moreno CS, Walker CL, Kucuk O.

Arch Biochem Biophys. 2015 Apr 15;572:36-9. doi: 10.1016/j.abb.2015.01.006. Epub 2015 Jan 17.

PMID:
25602702
8.

How aspartame prevents the toxicity of ochratoxin A.

Creppy EE, Baudrimont I, Anne-Marie.

J Toxicol Sci. 1998 Jul;23 Suppl 2:165-72.

9.
10.
11.

[Ochratoxin A, ubiquitous mycotoxin contaminating human food].

Pfohl-Leszkowicz A.

C R Seances Soc Biol Fil. 1994;188(4):335-53. Review. French.

PMID:
7736257
12.

Niban gene is commonly expressed in the renal tumors: a new candidate marker for renal carcinogenesis.

Adachi H, Majima S, Kon S, Kobayashi T, Kajino K, Mitani H, Hirayama Y, Shiina H, Igawa M, Hino O.

Oncogene. 2004 Apr 22;23(19):3495-500.

PMID:
14990989
13.
14.
15.

Oncological outcomes in rats given nephrocarcinogenic exposure to dietary ochratoxin a, followed by the tumour promoter sodium barbital for life: a pilot study.

Mantle PG, Dobrota M, Gillett CE, Odell EW, Pinder SE.

Toxins (Basel). 2010 Apr;2(4):552-71. doi: 10.3390/toxins2040552. Epub 2010 Mar 31.

16.
18.

Phospho-S6 ribosomal protein: a potential new predictive sarcoma marker for targeted mTOR therapy.

Iwenofu OH, Lackman RD, Staddon AP, Goodwin DG, Haupt HM, Brooks JS.

Mod Pathol. 2008 Mar;21(3):231-7. Epub 2007 Dec 21.

19.

Mitotic lymphoma cells are characterized by high expression of phosphorylated ribosomal S6 protein.

Egervári G, Márk A, Hajdu M, Barna G, Sápi Z, Krenács T, Kopper L, Sebestyén A.

Histochem Cell Biol. 2011 Apr;135(4):409-17. doi: 10.1007/s00418-011-0803-5. Epub 2011 Mar 20.

PMID:
21424608
20.

Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies).

National Toxicology Program.

Natl Toxicol Program Tech Rep Ser. 1989 May;358:1-142.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk